Arcus Biosciences, Inc. (RCUS)

25.45 -0.35 (-1.36%) USD  |  NYSE  |  Dec 09, 14:46
More

Arcus Biosciences EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for RCUS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Actinium Pharmaceuticals, Inc. Upgrade
Apyx Medical Corp. Upgrade
Gilead Sciences, Inc. Upgrade
Merck & Co., Inc. Upgrade
Karyopharm Therapeutics, Inc. Upgrade